Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

3 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07105332Not ApplicableTerminated

Feasibility Trial of a Sub-conjunctival Insert

Role: lead

NCT06867965Not ApplicableCompleted

Feasibility Study of a Novel Subcutaneous Continuous Glucose Monitoring System in Diabetics

Role: lead

NCT06868043Not ApplicableTerminated

A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days

Role: lead

NCT00999856Not ApplicableTerminated

Investigation of a Sub-Conjunctival Insert

Role: lead

NCT05133973Not ApplicableCompleted

Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients

Role: lead

NCT04152408Not ApplicableCompleted

Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor

Role: lead

All 6 trials loaded